NCT06019754

Brief Summary

lumbosacral plexus block (LSPB) has been widely applied in orthopedics departments due to its advantages, including reduction in the application of opiates, decreasing the occurrence of acute pain, promoting early activation, and shortening the time of hospital stay. LSPB is a peripheral regional technique of anesthesia and analgesia, that provides a block of the main components of the lumbosacral plexus.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 25, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 31, 2023

Completed
10 days until next milestone

Study Start

First participant enrolled

September 10, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 4, 2024

Completed
Last Updated

August 11, 2025

Status Verified

August 1, 2023

Enrollment Period

12 months

First QC Date

August 25, 2023

Last Update Submit

August 5, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total intraoperative and postoperative opioid consumption

    The total fentanyl doses consumed in the entire operative procedure and morphine consumed for 24 hours postoperative will be calculated.

    Total fentanyl used intraoperative and total morphine consumed up to 24 hours postoperative

Secondary Outcomes (2)

  • (NRS) score assessment pre-block, 30 min post-block , and postoperatively in the recovery room, and then it will be repeated 3 h, 6h, 12h, and 24, hours

    preoperative and postoperatively pain (NRS) score assessment for 24 hours

  • Block success assessment using perfusion index (PI) before and after performing the block

    Recording Perfusion index readings at baseline and 10, 20, 30 min. post block

Study Arms (2)

Control group

PLACEBO COMPARATOR

patients who will be recruited in the control group will receive general anesthesia only

Procedure: one point combined Lumbar and sacral plexus block

Interventional group

ACTIVE COMPARATOR

Patients who will be recruited in the Interventional will receive one point combined lumbar and sacral plexus block. then they will receive general anesthesia

Procedure: one point combined Lumbar and sacral plexus block

Interventions

performing an ultrasound-guided one-point combined Lumbar and sacral plexus block using a one-point puncture. Block success will be assessed using the perfusion index (PI) before and after performing the block

Also known as: No block intervention in control group
Control groupInterventional group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • ASA I-II.
  • patients scheduled for unilateral femur or tibial surgery necessitate knee joint intervention
  • patients who have severe pain hindering changing their position or patients who have spinal fractures or refusing spinal anesthesia.
  • patients with the capability of communication

You may not qualify if:

  • puncture site infection
  • patients with coagulation disorders
  • patients who refuse to participate or withdraw due to personal reasons
  • allergy to local anesthetics.
  • past surgery at the site of the block
  • hip ankylosis
  • drug abuse
  • Body mass index ≥ 35 kg/m2
  • peripheral vascular insufficiency
  • use of alpha or beta blocker agents
  • Nerve injury or neuropathy of the affected lower limb
  • cardiovascular or respiratory decompansation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine - Zagazig University

Zagazig, 44519, Egypt

Location

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Naglaa Abdelhaleem, MD

    Faculty of medicine, Zagazig University Hospitals

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Randomization assignments will be kept in sealed envelopes until all preprocedural measurements will be completed
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Using a point puncture approach instead of two punctures to perform lumbosacral plexuses block in the interventional group.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer, Anesthesia and Surgical Intensive Care department, Faculty of Medicine

Study Record Dates

First Submitted

August 25, 2023

First Posted

August 31, 2023

Study Start

September 10, 2023

Primary Completion

September 1, 2024

Study Completion

September 4, 2024

Last Updated

August 11, 2025

Record last verified: 2023-08

Locations